Tag: neoral

Expert Shares Practical Considerations for Dupilumab Treatment

Clinicians who struggle to get dupilumab approved for their patients with moderate to severe atopic dermatitis (AD) are not alone. This scenario was illustrated in...

Study Estimates Incidence of Dupilumab-Related Conjunctivitis

One in 15 patients who start dupilumab treatment may develop conjunctivitis during the first 6 months, most of which is manageable with ophthalmic treatments, results...